Review





Similar Products

94
ABclonal Biotechnology p ampk
RNA-Seq analysis and validation of mouse liver following FSP intervention. (A) Heatmap of hepatic gene expression profiles in vehicle group and FSP-2X group, with red and green indicating up- and down-regulated genes respectively ( n = 3); (B) Volcano plot displaying overall distribution of DEGs in FSP-treated liver tissues ( n = 3); (C) Bubble chart of KEGG pathway enrichment analysis for DEGs ( n = 3); (D) Heatmap visualization of differentially expressed genes ( n = 3); (E) mRNA expression analysis of target genes ( n = 6); (F, G) Expression levels and semi-quantitative analysis of key proteins in <t>AdipoRs-AMPK</t> signaling pathway ( n = 3); (H, I) Regulatory effects of FSP on proteins related to inflammation, oxidative stress, mitochondrial function and lactate metabolism ( n = 3); (J) mRNA levels of mitochondrial biogenesis genes Nrf1 (NRF1) and Tfam (TFAM) ( n = 6); (K) Mitochondrial DNA copy number in mouse liver tissues ( n = 6); (L–Q) Immunohistochemical staining and statistical analysis of PGC1α, TFAM and COXIV proteins (Scale bar: 20 μm, Total magnification: 200x, n = 5); (R) Hepatic ATP content ( n = 5); (S) ROS levels in liver tissues ( n = 4). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.
P Ampk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/ADIPOR2+Rabbit+pAb/pmc13312815-159-13-14
Average 94 stars, based on 1 article reviews
p ampk - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti p ampk
RNA-Seq analysis and validation of mouse liver following FSP intervention. (A) Heatmap of hepatic gene expression profiles in vehicle group and FSP-2X group, with red and green indicating up- and down-regulated genes respectively ( n = 3); (B) Volcano plot displaying overall distribution of DEGs in FSP-treated liver tissues ( n = 3); (C) Bubble chart of KEGG pathway enrichment analysis for DEGs ( n = 3); (D) Heatmap visualization of differentially expressed genes ( n = 3); (E) mRNA expression analysis of target genes ( n = 6); (F, G) Expression levels and semi-quantitative analysis of key proteins in <t>AdipoRs-AMPK</t> signaling pathway ( n = 3); (H, I) Regulatory effects of FSP on proteins related to inflammation, oxidative stress, mitochondrial function and lactate metabolism ( n = 3); (J) mRNA levels of mitochondrial biogenesis genes Nrf1 (NRF1) and Tfam (TFAM) ( n = 6); (K) Mitochondrial DNA copy number in mouse liver tissues ( n = 6); (L–Q) Immunohistochemical staining and statistical analysis of PGC1α, TFAM and COXIV proteins (Scale bar: 20 μm, Total magnification: 200x, n = 5); (R) Hepatic ATP content ( n = 5); (S) ROS levels in liver tissues ( n = 4). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.
Anti P Ampk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/Phospho-AMPK%CE%B11-S496+Rabbit+mAb/pm42191057-88-36-37
Average 94 stars, based on 1 article reviews
anti p ampk - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Affinity Biosciences anti p prkaa ampk
RNA-Seq analysis and validation of mouse liver following FSP intervention. (A) Heatmap of hepatic gene expression profiles in vehicle group and FSP-2X group, with red and green indicating up- and down-regulated genes respectively ( n = 3); (B) Volcano plot displaying overall distribution of DEGs in FSP-treated liver tissues ( n = 3); (C) Bubble chart of KEGG pathway enrichment analysis for DEGs ( n = 3); (D) Heatmap visualization of differentially expressed genes ( n = 3); (E) mRNA expression analysis of target genes ( n = 6); (F, G) Expression levels and semi-quantitative analysis of key proteins in <t>AdipoRs-AMPK</t> signaling pathway ( n = 3); (H, I) Regulatory effects of FSP on proteins related to inflammation, oxidative stress, mitochondrial function and lactate metabolism ( n = 3); (J) mRNA levels of mitochondrial biogenesis genes Nrf1 (NRF1) and Tfam (TFAM) ( n = 6); (K) Mitochondrial DNA copy number in mouse liver tissues ( n = 6); (L–Q) Immunohistochemical staining and statistical analysis of PGC1α, TFAM and COXIV proteins (Scale bar: 20 μm, Total magnification: 200x, n = 5); (R) Hepatic ATP content ( n = 5); (S) ROS levels in liver tissues ( n = 4). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.
Anti P Prkaa Ampk, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/ampk%CE%B1+anti+p/pm42152481-327-12-16
Average 86 stars, based on 1 article reviews
anti p prkaa ampk - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc p ampk
Transcriptomic Analysis Indicates Mg and Al-Mg Alter Gene Expression Patterns in Hepatocellular and Pancreatic Cancer Cells. (A) High-throughput sequencing of PANC-1, PANC-1-Mg, PANC-1-Al-Mg, Huh7, Huh7-Mg, and Huh7-Al-Mg groups; heatmap showing sample correlations. (B) Volcano plots illustrating differential gene expression in Huh7 and PANC-1 cells after Mg or Al-Mg treatment. (C) GO enrichment analysis of differentially expressed genes following Mg or Al-Mg treatment. (D) KEGG pathway enrichment analysis of differentially expressed genes after Mg or Al-Mg treatment. (E) GSEA enrichment analysis of gene expression profiles post Mg or Al-Mg treatment. (F) Western blot analysis of <t>AMPK,</t> p-AMPK and CPT1B expression in PANC-1 cells after Mg or Al-Mg exposure with or without AMPK agonist. (G) PPI network analysis of differentially expressed genes in Mg or Al-Mg-treated cells. (H) Integrated analysis of metabolomic and transcriptomic data by MetaboAnalyst 6.0.
P Ampk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/pmc12796606-184-4-6
Average 86 stars, based on 1 article reviews
p ampk - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc p ampk thr 172
Alteration of muscle FGF21 and downstream signaling in Ogg1 Tg mice. A , volcano plot of differentially expressed genes (DEGs) in skeletal muscle of Ogg1 Tg mice. Fgf21 is the most upregulated gene among all DEGs. B , Fgf21 gene expression was measured in major tissues of WT and Ogg1 Tg mice using quantitative PCR. Gene expressions were normalized to 18S rRNA expression. C , plasma FGF21was measured in WT and Ogg1 Tg mice using ELISA. D and E , phosphorylation of <t>AMPK</t> and ACC was measured in the skeletal muscle of WT and Ogg1 Tg mice using PAGE, and images were quantified using ImageJ. (n = 3–7); data are expressed as mean ± SD; ∗ p < 0.05 relative to WT. ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein; FGF21, fibroblast growth factor 21; Ogg1 Tg , OGG1-transgenic.
P Ampk Thr 172, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/pmc13068818-5-0-4
Average 86 stars, based on 1 article reviews
p ampk thr 172 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc rabbit anti p ampk thr172
Alteration of muscle FGF21 and downstream signaling in Ogg1 Tg mice. A , volcano plot of differentially expressed genes (DEGs) in skeletal muscle of Ogg1 Tg mice. Fgf21 is the most upregulated gene among all DEGs. B , Fgf21 gene expression was measured in major tissues of WT and Ogg1 Tg mice using quantitative PCR. Gene expressions were normalized to 18S rRNA expression. C , plasma FGF21was measured in WT and Ogg1 Tg mice using ELISA. D and E , phosphorylation of <t>AMPK</t> and ACC was measured in the skeletal muscle of WT and Ogg1 Tg mice using PAGE, and images were quantified using ImageJ. (n = 3–7); data are expressed as mean ± SD; ∗ p < 0.05 relative to WT. ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein; FGF21, fibroblast growth factor 21; Ogg1 Tg , OGG1-transgenic.
Rabbit Anti P Ampk Thr172, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/pmc13059122-18-0-4
Average 86 stars, based on 1 article reviews
rabbit anti p ampk thr172 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc p ampkalpha thr 172 40h9 rabbit mab
( A ) Western blot analysis of female mouse livers fed HFD containing doxycycline (Doxy) to express constitutive active AMPK [a1(1-312); AMPK CA ] for 7 days compared to control livers. ( B ) Immunohistochemical analysis of livers from male control and AMPK CA mice fed HFD+Doxy for 7 months. Scale bars, 100 μm. Right: Quantification of the staining intensity for P-Thr 172 AMPK and P-Ser 79 ACC staining. n = 6 to 10. ±SEM, Welch t test. ( C ) Representative whole-mount (top) and MRI (bottom) image of male control and AMPK CA livers 9 months post–DEN injection. Yellow dashed lines indicate tumors. ( D ) Quantification of the tumor number in male control and AMPK CA livers 6 and 9 months post–DEN injection based on MRI images. 6 months: N = 5 to 7; 9 months: N = 16 to 17; Fisher least significant difference (LSD) test. ( E ) Quantification of the serum AFP levels in control and AMPK CA male mice 6 and 9 months post–DEN injection. n = 9 to 15. Fisher LSD test. * P < 0.05; *** P < 0.001; **** P < 0.0001.
P Ampkalpha Thr 172 40h9 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ampk%CE%B1/pmc13068069-3-0-8
Average 86 stars, based on 1 article reviews
p ampkalpha thr 172 40h9 rabbit mab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


RNA-Seq analysis and validation of mouse liver following FSP intervention. (A) Heatmap of hepatic gene expression profiles in vehicle group and FSP-2X group, with red and green indicating up- and down-regulated genes respectively ( n = 3); (B) Volcano plot displaying overall distribution of DEGs in FSP-treated liver tissues ( n = 3); (C) Bubble chart of KEGG pathway enrichment analysis for DEGs ( n = 3); (D) Heatmap visualization of differentially expressed genes ( n = 3); (E) mRNA expression analysis of target genes ( n = 6); (F, G) Expression levels and semi-quantitative analysis of key proteins in AdipoRs-AMPK signaling pathway ( n = 3); (H, I) Regulatory effects of FSP on proteins related to inflammation, oxidative stress, mitochondrial function and lactate metabolism ( n = 3); (J) mRNA levels of mitochondrial biogenesis genes Nrf1 (NRF1) and Tfam (TFAM) ( n = 6); (K) Mitochondrial DNA copy number in mouse liver tissues ( n = 6); (L–Q) Immunohistochemical staining and statistical analysis of PGC1α, TFAM and COXIV proteins (Scale bar: 20 μm, Total magnification: 200x, n = 5); (R) Hepatic ATP content ( n = 5); (S) ROS levels in liver tissues ( n = 4). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Journal: Frontiers in Nutrition

Article Title: The herbal pair of Smilax glabra Roxb. and Ficus hirta Vahl. improves exercise performance by regulating mitochondrial function via the adiponection receptors-mediated AMPK signaling pathway

doi: 10.3389/fnut.2026.1782001

Figure Lengend Snippet: RNA-Seq analysis and validation of mouse liver following FSP intervention. (A) Heatmap of hepatic gene expression profiles in vehicle group and FSP-2X group, with red and green indicating up- and down-regulated genes respectively ( n = 3); (B) Volcano plot displaying overall distribution of DEGs in FSP-treated liver tissues ( n = 3); (C) Bubble chart of KEGG pathway enrichment analysis for DEGs ( n = 3); (D) Heatmap visualization of differentially expressed genes ( n = 3); (E) mRNA expression analysis of target genes ( n = 6); (F, G) Expression levels and semi-quantitative analysis of key proteins in AdipoRs-AMPK signaling pathway ( n = 3); (H, I) Regulatory effects of FSP on proteins related to inflammation, oxidative stress, mitochondrial function and lactate metabolism ( n = 3); (J) mRNA levels of mitochondrial biogenesis genes Nrf1 (NRF1) and Tfam (TFAM) ( n = 6); (K) Mitochondrial DNA copy number in mouse liver tissues ( n = 6); (L–Q) Immunohistochemical staining and statistical analysis of PGC1α, TFAM and COXIV proteins (Scale bar: 20 μm, Total magnification: 200x, n = 5); (R) Hepatic ATP content ( n = 5); (S) ROS levels in liver tissues ( n = 4). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Article Snippet: The specific antibodies used were as follows: AdipoR1 (Abclonal, A1509), AdipoR2 (Abclonal, A12777), p-AMPK (Abclonal, AP1441), AMPK (Abclonal, A1229), p-LKB1 (Abclonal, AP0601), LKB1 (Abclonal, A22636), PGC1α (Proteintech, 66369-1-Ig), SIRT1 (Proteintech, 13161-1-AP), LDHB (Proteintech, 14824-1-AP), COXIV (Cell Signaling Technology, 3E11), TFAM (Abclonal, A3173), NRF2 (Proteintech, 16396-1-AP), HO-1 (Abclonal, A19062), TNFα (Proteintech, 80258-6-RR), COX2 (Abclonal, A3560), and β-actin (Proteintech, 20536-1-AP).

Techniques: RNA Sequencing, Biomarker Discovery, Gene Expression, Expressing, Immunohistochemical staining, Staining

Effects of FSP serum treatment on gene expression in HepG2 cells. (A) Experimental design of FSP serum treatment in HepG2 cells (Created in https://BioRender.com ); (B, C) Impact of FSP serum on HepG2 cell proliferation capacity and quantitative analysis ( n = 6); (D) Transcript levels of differentially expressed genes and mitochondrial biogenesis-related genes (Nrf1/NRF1, Tfam/TFAM) in HepG2 cells ( n = 6); (E, F) Protein expression and semi-quantification of key AdipoRs-AMPK pathway components in HepG2 cells ( n = 3); (G, H) Effects of FSP serum on inflammation, oxidative stress, mitochondrial function and lactate metabolism-related proteins with semi-quantitative analysis ( n = 3); (I) Immunofluorescence co-localization of SIRT1 and PGC-1α proteins in HepG2 cells (Scale bar: 20 μm, Total magnification: 200x); (J, K) Immunofluorescence detection of mitochondrial function proteins COXIV and TFAM (Scale bar: 20 μm, Total magnification: 200x); (L, M) Mitochondrial membrane potential assay (JC-1) and analysis (Scale bar: 20 μm, Total magnification: 200x, n = 5). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Journal: Frontiers in Nutrition

Article Title: The herbal pair of Smilax glabra Roxb. and Ficus hirta Vahl. improves exercise performance by regulating mitochondrial function via the adiponection receptors-mediated AMPK signaling pathway

doi: 10.3389/fnut.2026.1782001

Figure Lengend Snippet: Effects of FSP serum treatment on gene expression in HepG2 cells. (A) Experimental design of FSP serum treatment in HepG2 cells (Created in https://BioRender.com ); (B, C) Impact of FSP serum on HepG2 cell proliferation capacity and quantitative analysis ( n = 6); (D) Transcript levels of differentially expressed genes and mitochondrial biogenesis-related genes (Nrf1/NRF1, Tfam/TFAM) in HepG2 cells ( n = 6); (E, F) Protein expression and semi-quantification of key AdipoRs-AMPK pathway components in HepG2 cells ( n = 3); (G, H) Effects of FSP serum on inflammation, oxidative stress, mitochondrial function and lactate metabolism-related proteins with semi-quantitative analysis ( n = 3); (I) Immunofluorescence co-localization of SIRT1 and PGC-1α proteins in HepG2 cells (Scale bar: 20 μm, Total magnification: 200x); (J, K) Immunofluorescence detection of mitochondrial function proteins COXIV and TFAM (Scale bar: 20 μm, Total magnification: 200x); (L, M) Mitochondrial membrane potential assay (JC-1) and analysis (Scale bar: 20 μm, Total magnification: 200x, n = 5). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Article Snippet: The specific antibodies used were as follows: AdipoR1 (Abclonal, A1509), AdipoR2 (Abclonal, A12777), p-AMPK (Abclonal, AP1441), AMPK (Abclonal, A1229), p-LKB1 (Abclonal, AP0601), LKB1 (Abclonal, A22636), PGC1α (Proteintech, 66369-1-Ig), SIRT1 (Proteintech, 13161-1-AP), LDHB (Proteintech, 14824-1-AP), COXIV (Cell Signaling Technology, 3E11), TFAM (Abclonal, A3173), NRF2 (Proteintech, 16396-1-AP), HO-1 (Abclonal, A19062), TNFα (Proteintech, 80258-6-RR), COX2 (Abclonal, A3560), and β-actin (Proteintech, 20536-1-AP).

Techniques: Gene Expression, Expressing, Immunofluorescence, Membrane

AMPK inhibition reverses biological effects of FSP serum intervention. (A) AMPK inhibition experiment in HepG2 cells under FSP serum intervention (Created in https://BioRender.com ); (B) Transcript levels of AMPK downstream effectors (SIRT1, PGC-1α) and mitochondrial genes (Nrf1/NRF1, Tfam/TFAM) ( n = 6); (C, D) Protein expression and semi-quantitative analysis of AMPK pathway molecules after AMPK inhibitor intervention ( n = 3); (E, F) Mitochondrial DNA copy number analysis ( n = 4); (G) Measurement of cellular ATP content ( n = 3); (H) Detection of cellular reactive oxygen species (ROS) levels ( n = 3); (I) SIRT1 and PGC-1α immunofluorescence co-localization (Scale bar: 20 μm, Total magnification: 200x); (J, K) Mitochondrial membrane potential (JC-1) staining and analysis (Scale bar: 20 μm, Total magnification: 200x, n = 5); (L–N) TEM analysis of mitochondrial ultrastructure with mitochondrial number ( n = 5) and area quantification ( n = 100) (Scale bar: 1/0.2 μm, Total magnification: 20,000/80,000x). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001compared to the vehicle gro,Q22up.

Journal: Frontiers in Nutrition

Article Title: The herbal pair of Smilax glabra Roxb. and Ficus hirta Vahl. improves exercise performance by regulating mitochondrial function via the adiponection receptors-mediated AMPK signaling pathway

doi: 10.3389/fnut.2026.1782001

Figure Lengend Snippet: AMPK inhibition reverses biological effects of FSP serum intervention. (A) AMPK inhibition experiment in HepG2 cells under FSP serum intervention (Created in https://BioRender.com ); (B) Transcript levels of AMPK downstream effectors (SIRT1, PGC-1α) and mitochondrial genes (Nrf1/NRF1, Tfam/TFAM) ( n = 6); (C, D) Protein expression and semi-quantitative analysis of AMPK pathway molecules after AMPK inhibitor intervention ( n = 3); (E, F) Mitochondrial DNA copy number analysis ( n = 4); (G) Measurement of cellular ATP content ( n = 3); (H) Detection of cellular reactive oxygen species (ROS) levels ( n = 3); (I) SIRT1 and PGC-1α immunofluorescence co-localization (Scale bar: 20 μm, Total magnification: 200x); (J, K) Mitochondrial membrane potential (JC-1) staining and analysis (Scale bar: 20 μm, Total magnification: 200x, n = 5); (L–N) TEM analysis of mitochondrial ultrastructure with mitochondrial number ( n = 5) and area quantification ( n = 100) (Scale bar: 1/0.2 μm, Total magnification: 20,000/80,000x). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001compared to the vehicle gro,Q22up.

Article Snippet: The specific antibodies used were as follows: AdipoR1 (Abclonal, A1509), AdipoR2 (Abclonal, A12777), p-AMPK (Abclonal, AP1441), AMPK (Abclonal, A1229), p-LKB1 (Abclonal, AP0601), LKB1 (Abclonal, A22636), PGC1α (Proteintech, 66369-1-Ig), SIRT1 (Proteintech, 13161-1-AP), LDHB (Proteintech, 14824-1-AP), COXIV (Cell Signaling Technology, 3E11), TFAM (Abclonal, A3173), NRF2 (Proteintech, 16396-1-AP), HO-1 (Abclonal, A19062), TNFα (Proteintech, 80258-6-RR), COX2 (Abclonal, A3560), and β-actin (Proteintech, 20536-1-AP).

Techniques: Inhibition, Expressing, Immunofluorescence, Membrane, Staining

Synergistic activation of the AdipoRs-AMPK pathway by taxifolin and apigenin combination (A) Schematic design of monomer compound cell experiments (Created in https://BioRender.com ); (B) mRNA expression levels of STRT1, Ppargc1a, Nrf1 (NRF1), and Tfam (TFAM) ( n = 6); (C, D) Protein expression in AdipoRs-AMPK pathway and mitochondrial function ( n = 3); (E, F) Mitochondrial DNA copy number detection ( n = 6); (G) Intracellular ATP content measurement ( n = 3); (H) Detection of reactive oxygen species (ROS) levels ( n = 5); (I, J) Measurement of mitochondrial membrane potential (JC-1) (Scale bar: 20 μm, Total magnification: 200x, n = 5); (K–M) Transmission electron microscopy (TEM) observation of mitochondrial ultrastructure (Scale bar: 1/0.2 μm, Total magnification: 20,000/80,000x), statistical analysis of mitochondrial quantity ( n = 5) and mitochondrial area ( n = 100). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Journal: Frontiers in Nutrition

Article Title: The herbal pair of Smilax glabra Roxb. and Ficus hirta Vahl. improves exercise performance by regulating mitochondrial function via the adiponection receptors-mediated AMPK signaling pathway

doi: 10.3389/fnut.2026.1782001

Figure Lengend Snippet: Synergistic activation of the AdipoRs-AMPK pathway by taxifolin and apigenin combination (A) Schematic design of monomer compound cell experiments (Created in https://BioRender.com ); (B) mRNA expression levels of STRT1, Ppargc1a, Nrf1 (NRF1), and Tfam (TFAM) ( n = 6); (C, D) Protein expression in AdipoRs-AMPK pathway and mitochondrial function ( n = 3); (E, F) Mitochondrial DNA copy number detection ( n = 6); (G) Intracellular ATP content measurement ( n = 3); (H) Detection of reactive oxygen species (ROS) levels ( n = 5); (I, J) Measurement of mitochondrial membrane potential (JC-1) (Scale bar: 20 μm, Total magnification: 200x, n = 5); (K–M) Transmission electron microscopy (TEM) observation of mitochondrial ultrastructure (Scale bar: 1/0.2 μm, Total magnification: 20,000/80,000x), statistical analysis of mitochondrial quantity ( n = 5) and mitochondrial area ( n = 100). Results are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the vehicle group.

Article Snippet: The specific antibodies used were as follows: AdipoR1 (Abclonal, A1509), AdipoR2 (Abclonal, A12777), p-AMPK (Abclonal, AP1441), AMPK (Abclonal, A1229), p-LKB1 (Abclonal, AP0601), LKB1 (Abclonal, A22636), PGC1α (Proteintech, 66369-1-Ig), SIRT1 (Proteintech, 13161-1-AP), LDHB (Proteintech, 14824-1-AP), COXIV (Cell Signaling Technology, 3E11), TFAM (Abclonal, A3173), NRF2 (Proteintech, 16396-1-AP), HO-1 (Abclonal, A19062), TNFα (Proteintech, 80258-6-RR), COX2 (Abclonal, A3560), and β-actin (Proteintech, 20536-1-AP).

Techniques: Activation Assay, Expressing, Membrane, Transmission Assay, Electron Microscopy

Transcriptomic Analysis Indicates Mg and Al-Mg Alter Gene Expression Patterns in Hepatocellular and Pancreatic Cancer Cells. (A) High-throughput sequencing of PANC-1, PANC-1-Mg, PANC-1-Al-Mg, Huh7, Huh7-Mg, and Huh7-Al-Mg groups; heatmap showing sample correlations. (B) Volcano plots illustrating differential gene expression in Huh7 and PANC-1 cells after Mg or Al-Mg treatment. (C) GO enrichment analysis of differentially expressed genes following Mg or Al-Mg treatment. (D) KEGG pathway enrichment analysis of differentially expressed genes after Mg or Al-Mg treatment. (E) GSEA enrichment analysis of gene expression profiles post Mg or Al-Mg treatment. (F) Western blot analysis of AMPK, p-AMPK and CPT1B expression in PANC-1 cells after Mg or Al-Mg exposure with or without AMPK agonist. (G) PPI network analysis of differentially expressed genes in Mg or Al-Mg-treated cells. (H) Integrated analysis of metabolomic and transcriptomic data by MetaboAnalyst 6.0.

Journal: Bioactive Materials

Article Title: A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer

doi: 10.1016/j.bioactmat.2025.12.039

Figure Lengend Snippet: Transcriptomic Analysis Indicates Mg and Al-Mg Alter Gene Expression Patterns in Hepatocellular and Pancreatic Cancer Cells. (A) High-throughput sequencing of PANC-1, PANC-1-Mg, PANC-1-Al-Mg, Huh7, Huh7-Mg, and Huh7-Al-Mg groups; heatmap showing sample correlations. (B) Volcano plots illustrating differential gene expression in Huh7 and PANC-1 cells after Mg or Al-Mg treatment. (C) GO enrichment analysis of differentially expressed genes following Mg or Al-Mg treatment. (D) KEGG pathway enrichment analysis of differentially expressed genes after Mg or Al-Mg treatment. (E) GSEA enrichment analysis of gene expression profiles post Mg or Al-Mg treatment. (F) Western blot analysis of AMPK, p-AMPK and CPT1B expression in PANC-1 cells after Mg or Al-Mg exposure with or without AMPK agonist. (G) PPI network analysis of differentially expressed genes in Mg or Al-Mg-treated cells. (H) Integrated analysis of metabolomic and transcriptomic data by MetaboAnalyst 6.0.

Article Snippet: Primary antibodies used included p-AMPK (1:100, CST, 2535), Ki-67 (1:1000, Servicebio, GB111499-50), E-cadherin (1:500, Servicebio, GB12083-100), N-cadherin (1:500, Proteintech, SA00013-4), and Vimentin (1:2000, Servicebio, GB11192-100).

Techniques: Gene Expression, Next-Generation Sequencing, Western Blot, Expressing

Alteration of muscle FGF21 and downstream signaling in Ogg1 Tg mice. A , volcano plot of differentially expressed genes (DEGs) in skeletal muscle of Ogg1 Tg mice. Fgf21 is the most upregulated gene among all DEGs. B , Fgf21 gene expression was measured in major tissues of WT and Ogg1 Tg mice using quantitative PCR. Gene expressions were normalized to 18S rRNA expression. C , plasma FGF21was measured in WT and Ogg1 Tg mice using ELISA. D and E , phosphorylation of AMPK and ACC was measured in the skeletal muscle of WT and Ogg1 Tg mice using PAGE, and images were quantified using ImageJ. (n = 3–7); data are expressed as mean ± SD; ∗ p < 0.05 relative to WT. ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein; FGF21, fibroblast growth factor 21; Ogg1 Tg , OGG1-transgenic.

Journal: The Journal of Biological Chemistry

Article Title: OGG1 increases exercise endurance via elevated skeletal muscle FGF21

doi: 10.1016/j.jbc.2026.111360

Figure Lengend Snippet: Alteration of muscle FGF21 and downstream signaling in Ogg1 Tg mice. A , volcano plot of differentially expressed genes (DEGs) in skeletal muscle of Ogg1 Tg mice. Fgf21 is the most upregulated gene among all DEGs. B , Fgf21 gene expression was measured in major tissues of WT and Ogg1 Tg mice using quantitative PCR. Gene expressions were normalized to 18S rRNA expression. C , plasma FGF21was measured in WT and Ogg1 Tg mice using ELISA. D and E , phosphorylation of AMPK and ACC was measured in the skeletal muscle of WT and Ogg1 Tg mice using PAGE, and images were quantified using ImageJ. (n = 3–7); data are expressed as mean ± SD; ∗ p < 0.05 relative to WT. ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein; FGF21, fibroblast growth factor 21; Ogg1 Tg , OGG1-transgenic.

Article Snippet: p-AMPK (Thr-172) , 2535- Cell Signaling Technologies , 1:1000.

Techniques: Gene Expression, Real-time Polymerase Chain Reaction, Expressing, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Phospho-proteomics, Transgenic Assay

( A ) Western blot analysis of female mouse livers fed HFD containing doxycycline (Doxy) to express constitutive active AMPK [a1(1-312); AMPK CA ] for 7 days compared to control livers. ( B ) Immunohistochemical analysis of livers from male control and AMPK CA mice fed HFD+Doxy for 7 months. Scale bars, 100 μm. Right: Quantification of the staining intensity for P-Thr 172 AMPK and P-Ser 79 ACC staining. n = 6 to 10. ±SEM, Welch t test. ( C ) Representative whole-mount (top) and MRI (bottom) image of male control and AMPK CA livers 9 months post–DEN injection. Yellow dashed lines indicate tumors. ( D ) Quantification of the tumor number in male control and AMPK CA livers 6 and 9 months post–DEN injection based on MRI images. 6 months: N = 5 to 7; 9 months: N = 16 to 17; Fisher least significant difference (LSD) test. ( E ) Quantification of the serum AFP levels in control and AMPK CA male mice 6 and 9 months post–DEN injection. n = 9 to 15. Fisher LSD test. * P < 0.05; *** P < 0.001; **** P < 0.0001.

Journal: Science Advances

Article Title: Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity

doi: 10.1126/sciadv.aea8017

Figure Lengend Snippet: ( A ) Western blot analysis of female mouse livers fed HFD containing doxycycline (Doxy) to express constitutive active AMPK [a1(1-312); AMPK CA ] for 7 days compared to control livers. ( B ) Immunohistochemical analysis of livers from male control and AMPK CA mice fed HFD+Doxy for 7 months. Scale bars, 100 μm. Right: Quantification of the staining intensity for P-Thr 172 AMPK and P-Ser 79 ACC staining. n = 6 to 10. ±SEM, Welch t test. ( C ) Representative whole-mount (top) and MRI (bottom) image of male control and AMPK CA livers 9 months post–DEN injection. Yellow dashed lines indicate tumors. ( D ) Quantification of the tumor number in male control and AMPK CA livers 6 and 9 months post–DEN injection based on MRI images. 6 months: N = 5 to 7; 9 months: N = 16 to 17; Fisher least significant difference (LSD) test. ( E ) Quantification of the serum AFP levels in control and AMPK CA male mice 6 and 9 months post–DEN injection. n = 9 to 15. Fisher LSD test. * P < 0.05; *** P < 0.001; **** P < 0.0001.

Article Snippet: P-AMPKalpha (Thr 172 ) (40H9) Rabbit mAb , Cell Signaling Technology , 2535.

Techniques: Western Blot, Control, Immunohistochemical staining, Staining, Injection

( A ) Quantification of the tumor size from MRI imaging at 6 and 9 months. n = 10 to 448. Log normal Welch t test. ( B ) Immunohistochemical analysis of BrdU incorporation in tumor tissue from control and AMPK CA livers following a 4-hour BrdU pulse (10 mg/kg). Scale bars, 100 μm. Right: Quantification of the number of positive cells per area. n = 13 to 17. Welch t test. ( C ) Gene expression of Ampka1 normalized to Actin in nontumor and tumor tissue. n = 5 to 6. ±SEM, Fisher LSD test. ( D ) Immunohistochemical analysis of P-Ser 79 ACC in nontumor and tumor tissue from control and AMPK CA livers. Scale bars, 100 μm. ( E ) Quantification of the staining intensity of P-Ser 79 ACC. n = 5 to 14. Fisher LSD test. ( F ) Immunohistochemical analysis of P-Thr 172 AMPK in nontumor and tumor tissue from control and AMPK CA livers. Scale bars, 100 μm. ( G ) Quantification of the staining intensity. n = 6 to 11. Fisher LSD test. ( H ) Western blot analysis of nontumor (NT) and tumor (T) tissue. VINCULIN as loading control. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: Science Advances

Article Title: Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity

doi: 10.1126/sciadv.aea8017

Figure Lengend Snippet: ( A ) Quantification of the tumor size from MRI imaging at 6 and 9 months. n = 10 to 448. Log normal Welch t test. ( B ) Immunohistochemical analysis of BrdU incorporation in tumor tissue from control and AMPK CA livers following a 4-hour BrdU pulse (10 mg/kg). Scale bars, 100 μm. Right: Quantification of the number of positive cells per area. n = 13 to 17. Welch t test. ( C ) Gene expression of Ampka1 normalized to Actin in nontumor and tumor tissue. n = 5 to 6. ±SEM, Fisher LSD test. ( D ) Immunohistochemical analysis of P-Ser 79 ACC in nontumor and tumor tissue from control and AMPK CA livers. Scale bars, 100 μm. ( E ) Quantification of the staining intensity of P-Ser 79 ACC. n = 5 to 14. Fisher LSD test. ( F ) Immunohistochemical analysis of P-Thr 172 AMPK in nontumor and tumor tissue from control and AMPK CA livers. Scale bars, 100 μm. ( G ) Quantification of the staining intensity. n = 6 to 11. Fisher LSD test. ( H ) Western blot analysis of nontumor (NT) and tumor (T) tissue. VINCULIN as loading control. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: P-AMPKalpha (Thr 172 ) (40H9) Rabbit mAb , Cell Signaling Technology , 2535.

Techniques: Imaging, Immunohistochemical staining, BrdU Incorporation Assay, Control, Gene Expression, Staining, Western Blot